HCMT
PTLA
Highland Capital Management (Texas)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | $43.2M | Buy |
1,592,979
+34,150
| +2% | +$927K | 2.53% | 6 |
|
2019
Q1 | $54.1M | Sell |
1,558,829
-23,300
| -1% | -$809K | 3.37% | 5 |
|
2018
Q4 | $30.9M | Buy |
1,582,129
+407,574
| +35% | +$7.96M | 2.37% | 7 |
|
2018
Q3 | $31.3M | Buy |
1,174,555
+474,735
| +68% | +$12.6M | 1.73% | 8 |
|
2018
Q2 | $26.4M | Buy |
699,820
+322,907
| +86% | +$12.2M | 1.5% | 11 |
|
2018
Q1 | $12.3M | Sell |
376,913
-67,600
| -15% | -$2.21M | 0.63% | 35 |
|
2017
Q4 | $21.6M | Buy |
444,513
+42,390
| +11% | +$2.06M | 0.99% | 19 |
|
2017
Q3 | $21.7M | Buy |
402,123
+382,123
| +1,911% | +$20.6M | 0.96% | 16 |
|
2017
Q2 | $1.12M | Sell |
20,000
-31,900
| -61% | -$1.79M | 0.05% | 164 |
|
2017
Q1 | $2.03M | Sell |
51,900
-5,000
| -9% | -$196K | 0.1% | 141 |
|
2016
Q4 | $1.28M | Buy |
56,900
+16,700
| +42% | +$375K | 0.06% | 152 |
|
2016
Q3 | $913K | Buy |
+40,200
| New | +$913K | 0.03% | 165 |
|
2016
Q2 | – | Sell |
-160,900
| Closed | -$3.28M | – | 266 |
|
2016
Q1 | $3.28M | Sell |
160,900
-131,990
| -45% | -$2.69M | 0.14% | 129 |
|
2015
Q4 | $15.1M | Sell |
292,890
-44,110
| -13% | -$2.27M | 0.48% | 52 |
|
2015
Q3 | $14.4M | Sell |
337,000
-114,791
| -25% | -$4.89M | 0.42% | 57 |
|
2015
Q2 | $20.6M | Buy |
451,791
+356,599
| +375% | +$16.2M | 0.42% | 51 |
|
2015
Q1 | $3.61M | Buy |
95,192
+45,392
| +91% | +$1.72M | 0.07% | 143 |
|
2014
Q4 | $1.41M | Buy |
+49,800
| New | +$1.41M | 0.05% | 146 |
|
2014
Q1 | – | Sell |
-8,834
| Closed | -$227K | – | 256 |
|
2013
Q4 | $227K | Buy |
+8,834
| New | +$227K | 0.01% | 173 |
|